DD265401A5 - Verfahren zur herstellung von 7-(azabicycloakyl)-chinolencarbonsaeure- und -naphthydridencarbonsaeure-derivaten - Google Patents

Verfahren zur herstellung von 7-(azabicycloakyl)-chinolencarbonsaeure- und -naphthydridencarbonsaeure-derivaten Download PDF

Info

Publication number
DD265401A5
DD265401A5 DD87299333A DD29933387A DD265401A5 DD 265401 A5 DD265401 A5 DD 265401A5 DD 87299333 A DD87299333 A DD 87299333A DD 29933387 A DD29933387 A DD 29933387A DD 265401 A5 DD265401 A5 DD 265401A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
oxo
acid
dihydro
cyclopropyl
Prior art date
Application number
DD87299333A
Other languages
German (de)
English (en)
Inventor
Uwe Petersen
Klaus Grohe
Thomas Schenke
Hermann Hagemann
Hans-Joachim Zeiler
Karl G Metzger
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD265401A5 publication Critical patent/DD265401A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD87299333A 1986-01-21 1987-01-19 Verfahren zur herstellung von 7-(azabicycloakyl)-chinolencarbonsaeure- und -naphthydridencarbonsaeure-derivaten DD265401A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601567 DE3601567A1 (de) 1986-01-21 1986-01-21 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate

Publications (1)

Publication Number Publication Date
DD265401A5 true DD265401A5 (de) 1989-03-01

Family

ID=6292237

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87299333A DD265401A5 (de) 1986-01-21 1987-01-19 Verfahren zur herstellung von 7-(azabicycloakyl)-chinolencarbonsaeure- und -naphthydridencarbonsaeure-derivaten

Country Status (16)

Country Link
EP (1) EP0230274A3 (no)
JP (1) JPS62169789A (no)
KR (1) KR870007176A (no)
CN (1) CN87100354A (no)
AU (1) AU6746387A (no)
DD (1) DD265401A5 (no)
DE (1) DE3601567A1 (no)
DK (1) DK29287A (no)
FI (1) FI870200A (no)
HU (1) HUT45531A (no)
IL (1) IL81291A0 (no)
NO (1) NO870126L (no)
PL (1) PL263735A1 (no)
PT (1) PT84135A (no)
SU (1) SU1538897A3 (no)
ZA (1) ZA87380B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83049A (en) * 1986-07-04 1991-12-12 Chemie Linz Ag 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
KR910003630B1 (ko) * 1988-06-17 1991-06-07 한국과학기술원 벤조일 아세틱 에스테르 유도체 및 그 제조방법
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
FR2656611B1 (fr) * 1990-01-04 1992-05-07 Hoechst France Nouvelles quinolones, leurs sels, utiles comme agents antimicrobiens, procede de preparation et leur application a titre de medicaments et compositions les renfermant.
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
US6184380B1 (en) 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281423A (en) * 1964-02-03 1966-10-25 Merck & Co Inc 1, 3-ethanopiperazines and process
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
IL74244A (en) * 1984-02-17 1988-06-30 Warner Lambert Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IN166416B (no) * 1985-09-18 1990-05-05 Pfizer

Also Published As

Publication number Publication date
FI870200A (fi) 1987-07-22
PT84135A (en) 1987-02-01
DE3601567A1 (de) 1987-07-23
EP0230274A2 (de) 1987-07-29
CN87100354A (zh) 1987-09-02
PL263735A1 (en) 1988-07-21
HUT45531A (en) 1988-07-28
SU1538897A3 (ru) 1990-01-23
EP0230274A3 (de) 1988-03-09
KR870007176A (ko) 1987-08-17
JPS62169789A (ja) 1987-07-25
NO870126L (no) 1987-07-22
AU6746387A (en) 1987-07-23
NO870126D0 (no) 1987-01-13
DK29287A (da) 1987-07-22
DK29287D0 (da) 1987-01-20
IL81291A0 (en) 1987-08-31
ZA87380B (en) 1987-09-30
FI870200A0 (fi) 1987-01-19

Similar Documents

Publication Publication Date Title
EP0350733B1 (de) 7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe
JP3046035B2 (ja) 5―アルキルキノロンカルボン酸類
EP0284935A1 (de) 5-Substituierte Chinolon- und Naphthyridoncarbonsäure-Derivate
EP0276700A1 (de) 8-Cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende antibakterielle Mittel
DD265401A5 (de) Verfahren zur herstellung von 7-(azabicycloakyl)-chinolencarbonsaeure- und -naphthydridencarbonsaeure-derivaten
EP0198192A1 (de) 7-Amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
DE4120646A1 (de) 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
EP0187376B1 (de) 6,7-Disubstituierte 1-Cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carbonsäuren
EP0224178B1 (de) 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
DE3814517A1 (de) Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE4032560A1 (de) 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
EP0235676B1 (de) 7-(1-Pyrrolidinyl)-chinoloncarbonsaeure-Derivate
EP0391169A2 (de) Enantiomerereine 7-(3-Amino-1-pyrrolidinyl)-chinolon-und-naphthyridoncarbonsäuren
EP0726270B1 (de) 1,6-Naphthyridoncarbonsäurederivate
AU668286B2 (en) Diazabicyclo(4.3.0)nonane and (3.3.0)octane heterocycles
DE3635218A1 (de) 7-amino-1-cyclopropyl-8-chlor-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
KR890005200B1 (ko) 7-(1-피롤리디닐)-퀴놀론카르복실산 유도체
JPH0348682A (ja) ピリドンカルボン酸化合物
IE19970856A1 (en) 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions
IE84193B1 (en) 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions
DE19506535A1 (de) 1,6-Naphthyridoncarbonsäurederivate
DD241258A5 (de) Verfahren zur herstellung 6,7-disubstituierter 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carbonsaeuren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee